Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group.
暂无分享,去创建一个
M. Slovak | F. Quintero-Rivera | G. Raca | R. Kanagal-Shamanna | S. Shetty | M. Fang | P. Lennon | M. Sukhanova | A. Yenamandra | S. Jeffries | A. Dixon-Mciver | A. Iqbal | Xinjie Xu | C. Bryke | D. Dash | Patricia T. Griepp | Emma Huxley | Jennelle C. Hodge